{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:34:15Z","timestamp":1791916455607,"version":"4.3.4"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11632005"],"award-info":[{"award-number":["11632005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11672086"],"award-info":[{"award-number":["11672086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.actbio.2021.04.050","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T13:07:21Z","timestamp":1620220041000},"page":"100-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Recent developments in next-generation occlusion devices"],"prefix":"10.1016","volume":"128","author":[{"given":"Cheng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5098-9871","authenticated-orcid":false,"given":"Jinsong","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2021.04.050_bib0001","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fped.2018.00128","article-title":"Long-term outcome of transcatheter device closure of perimembranous ventricular septal defects","volume":"6","author":"Mandal","year":"2018","journal-title":"Front. Pediatrics"},{"key":"10.1016\/j.actbio.2021.04.050_bib0002","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1540-8183.2007.00303.x","article-title":"ASD\/PFO Devices: What Is in the Pipeline?","volume":"20","author":"Majunke","year":"2007","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0003","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ccd.26968","article-title":"Transcatheter closure of patent ductus arteriosus using the AMPLATZER\u2122 duct occluder II (ADO II)","volume":"89","author":"Gruenstein","year":"2017","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0004","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ccd.24912","article-title":"Multicenter nit-occlud(R) PDA-R patent. Ductus arteriosus occlusion device trial: initial and six-month results","volume":"86","author":"Granja","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.33963\/KP.15172","article-title":"Watchman FLX: the initial Polish experience with a new device for left atrial appendage occlusion","volume":"78","author":"Grygier","year":"2020","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0006","first-page":"2188","article-title":"Percutaneous left atrial appendage closure with the lambre device for stroke prevention in atrial fibrillation: a prospective, multicenter clinical study","volume":"10","author":"Huang","year":"2017","journal-title":"JACC: Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0007","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","article-title":"The incidence of congenital heart disease","volume":"39","author":"Hoffman","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0008","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.actbio.2013.12.003","article-title":"Biomaterials and design in occlusion devices for cardiac defects: a review","volume":"10","author":"Huang","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0009","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.CIR.43.3.323","article-title":"Congenital heart disease in 56,109 births. Incidence and natural history","volume":"43","author":"Mitchell","year":"1971","journal-title":"Circulation"},{"key":"10.1016\/j.actbio.2021.04.050_bib0145","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/17434440.2016.1182860","article-title":"Historical developments of atrial septal defect closure devices: what we learn from the past","volume":"13","author":"Nassif","year":"2016","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.actbio.2021.04.050_bib0010","first-page":"963","article-title":"Patent foramen ovale closure with the SeptRx device: initial experience with the first \u201cin-tunnel\u201d device","volume":"3","author":"Zimmermann","year":"2010","journal-title":"JACC: Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.actbio.2021.04.050_bib0012","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ccd.10674","article-title":"Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: Initial and intermediate-term results of the U.S. multicenter clinical trial","volume":"60","author":"Hong","year":"2003","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0013","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcin.2008.09.013","article-title":"Late Results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer pfo occluder without intraprocedural echocardiography: effect of device size","volume":"2","author":"Wahl","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0014","first-page":"1022","author":"Saver","year":"2017","journal-title":"Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy After Stroke"},{"key":"10.1016\/j.actbio.2021.04.050_bib0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1047951117002396","article-title":"Transcatheter closure of congenital perimembranous ventricular septal defect using the Amplatzer duct occluder 2","volume":"28","author":"Zhao","year":"2018","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.actbio.2021.04.050_bib0016","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1093\/eurheartj\/suq006","article-title":"Transcatheter closure of congenital and acquired septal defects","volume":"12","author":"Spies","year":"2010","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.actbio.2021.04.050_bib0017","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ccd.27177","article-title":"Complete heart block following transcatheter closure of perimembranous VSD using amplatzer duct occluder II","volume":"92","author":"Ghosh","year":"2018","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8948249","article-title":"Transcatheter closure of perimembranous ventricular septal defects using different generations of amplatzer devices: multicenter experience","volume":"2020","author":"Mijangos-Vazquez","year":"2020","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0019","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1002\/ccd.27851","article-title":"Feasibility and 1-year outcome of transcatheter closure of perimembranous ventricular septal defects with different devices","volume":"93","author":"Shrestha","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00246-014-1017-0","article-title":"Follow-up of patients with interventional closure of ventricular septal defects with amplatzer duct occluder II","volume":"36","author":"Kanaan","year":"2015","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0021","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ccd.20423","article-title":"Transcatheter closure of patent ductus arteriosus with Nit-Occlud coils","volume":"65","author":"Celiker","year":"2005","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0022","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jcin.2014.06.019","article-title":"Results of the combined U.S. multicenter pivotal study and the continuing access study of the nit-occlud PDA device for percutaneous closure of patent ductus arteriosus","volume":"7","author":"Moore","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0023","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrcardio.2017.107","article-title":"Interventional and surgical occlusion of the left atrial appendage","volume":"14","author":"Caliskan","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jacc.2005.03.042","article-title":"Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation - Results from the international multi-center feasibility trials","volume":"46","author":"Ostermayer","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41551-017-0180-z","article-title":"Patient-specific design of a soft occluder for the left atrial appendage","volume":"2","author":"Robinson","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.actbio.2021.04.050_bib0026","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2021.04.050_bib0027","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tcm.2015.05.009","article-title":"Left atrial appendage isolation using percutaneous (endocardial\/epicardial) devices: pre-clinical and clinical experience","volume":"26","author":"Romero","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.actbio.2021.04.050_bib0028","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.actbio.2021.04.050_bib0029","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.actbio.2021.04.050_bib0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/imi.0b013e31822a2c42","article-title":"A novel biodegradable septal defect occluder: the \"Chinese Lantern\" design, proof of concept","volume":"6","author":"Wu","year":"2011","journal-title":"Innovations (Phila)"},{"key":"10.1016\/j.actbio.2021.04.050_bib0031","first-page":"1","article-title":"An innovative occluder for cardiac defect: 3D printing and a biocompatibility research based on self-developed bioabsorbable material-LA-GA-TMC","author":"Sun","year":"2020","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0032","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/joic.12550","article-title":"A novel totally biodegradable device for effective atrial septal defect closure: A 2-year study in sheep","volume":"31","author":"Lu","year":"2018","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0033","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ccd.22735","article-title":"Fully biodegradable septal defect occluder-A double umbrella design","volume":"76","author":"Duong-Hong","year":"2010","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2006.02.057","article-title":"Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: Development and preclinical evaluation of the BioSTAR device","volume":"48","author":"Jux","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ccd.28529","article-title":"Initial experiences with a novel biodegradable device for percutaneous closure of atrial septal defects: From preclinical study to first-in-human experience","volume":"95","author":"Li","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0036","first-page":"1","article-title":"Animal experimental study of the fully biodegradable atrial septal defect (ASD) occluder","volume":"2012","author":"Zhu","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0037","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jacc.2005.12.017","article-title":"Adverse Events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure","volume":"47","author":"Wertman","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0038","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/hrt.2006.098103","article-title":"Biocompatibility of septal defect closure devices","volume":"93","author":"Sigler","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.actbio.2021.04.050_bib0039","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/hc3301.092792","article-title":"Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system","volume":"104","author":"Zahn","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.actbio.2021.04.050_bib0040","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s10439-011-0368-4","article-title":"Novel biodegradable polycaprolactone occlusion device combining nanofibrous plga\/collagen membrane for closure of atrial septal defect (ASD)","volume":"39","author":"Liu","year":"2011","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.actbio.2021.04.050_bib0041","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4244\/EIJ-D-17-00006","article-title":"Carag bioresorbable septal occluder (CBSO): histopathology of experimental implants","volume":"13","author":"Sigler","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.actbio.2021.04.050_bib0042","first-page":"89","article-title":"Double BioDisk: a new bioprosthetic device for transcatheter closure of atrial septal defects - a feasibility study in adult sheep","volume":"46","author":"Pavcnik","year":"2012","journal-title":"Radiolo. Oncol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0043","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1002\/ccd.27852","article-title":"Study of biodegradable occluder of atrial septal defect in a porcine model","volume":"93","author":"Li","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0044","article-title":"4D-Printed biodegradable and remotely controllable shape memory occlusion devices","volume":"0","author":"Lin","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0045","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.jacc.2011.08.036","article-title":"Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high-risk patients with atrial fibrillation","volume":"58","author":"Toumanides","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0046","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/j.biomaterials.2013.08.055","article-title":"A 5-fluorouracil-loaded polydioxanone weft-knitted stent for the treatment of colorectal cancer","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.04.050_bib0047","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tcm.2018.08.008","article-title":"An overview of current and emerging devices for percutaneous left atrial appendage closure","volume":"29","author":"Chow","year":"2019","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.actbio.2021.04.050_bib0048","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0142-9612(00)00101-0","article-title":"Synthetic biodegradable polymers as orthopedic devices","volume":"21","author":"Middleton","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.04.050_bib0049","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10439-015-1455-8","article-title":"An overview of mechanical properties and material modeling of polylactide (PLA) for medical applications","volume":"44","author":"Bergstrom","year":"2016","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.actbio.2021.04.050_bib0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/19475411.2020.1729274","article-title":"The compatibility of polylactic acid and polybutylene succinate blends by molecular and mesoscopic dynamics","volume":"11","author":"Lin","year":"2020","journal-title":"Intern. J.Smart Nano Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0051","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.addr.2016.03.012","article-title":"Biocompatibility and safety of PLA and its copolymers","volume":"107","author":"Ramot","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.04.050_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.compscitech.2019.107866","article-title":"Personalized 4D printing of bioinspired tracheal scaffold concept based on magnetic stimulated shape memory composites","author":"Zhao","year":"2019","journal-title":"Composites Sci. Technol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.compositesa.2019.105571","article-title":"Magnetic programming of 4D printed shape memory composite structures","volume":"125","author":"Zhang","year":"2019","journal-title":"Composites Part A"},{"key":"10.1016\/j.actbio.2021.04.050_bib0054","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cej.2018.01.010","article-title":"Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems","volume":"340","author":"Da","year":"2018","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2021.04.050_bib0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/app.21116","article-title":"In vitro degradation behavior of electrospun polyglycolide, polylactide, and poly(lactide-co-glycolide)","volume":"95","author":"You","year":"2005","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.actbio.2021.04.050_bib0056","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000446313","article-title":"A novel-design poly-l-lactic acid biodegradable device for closure of atrial Septal Defect: long-term results in swine","volume":"135","author":"Xie","year":"2016","journal-title":"Cardiology"},{"key":"10.1016\/j.actbio.2021.04.050_bib0057","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1177\/0040517516660893","article-title":"Design and characterization of PDO biodegradable intravascular stents","volume":"87","author":"Wang","year":"2017","journal-title":"Text. Res. J."},{"key":"10.1016\/j.actbio.2021.04.050_bib0058","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejpb.2015.05.024","article-title":"Polydioxanone-based bio-materials for tissue engineering and drug\/gene delivery applications","volume":"97","author":"Goonoo","year":"2015","journal-title":"Eur. J. Pharma. Biopharma."},{"key":"10.1016\/j.actbio.2021.04.050_bib0059","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1016\/j.biomaterials.2010.06.057","article-title":"The biocompatibility of rapidly degrading polymeric stents in porcine carotid arteries","volume":"31","author":"Zamiri","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.04.050_bib0060","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/jbm.a.32458","article-title":"Evaluation of thrombogenic potential of electrospun bioresorbable vascular graft materials: acute monocyte tissue factor expression","volume":"92A","author":"Wolfe","year":"2010","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"10.1016\/j.actbio.2021.04.050_bib0061","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00240-007-0124-2","article-title":"Tissue reactions of suture materials (polyglactine 910, chromed catgut and polydioxanone) on rat bladder wall and their role in bladder stone formation","volume":"36","author":"Kosan","year":"2008","journal-title":"Urol. Res."},{"key":"10.1016\/j.actbio.2021.04.050_bib0062","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/DSS.0000000000000585","article-title":"Novel polydioxanone multifilament scaffold device for tissue regeneration","volume":"42","author":"Kim","year":"2016","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.actbio.2021.04.050_bib0063","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801213","article-title":"A biodegradable stent with surface functionalization of combined-therapy drugs for colorectal cancer","volume":"7","author":"Xie","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0064","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ccd.24580","article-title":"Development and preclinical evaluation of a biodegradable ventricular septal defect occluder","volume":"81","author":"Huang","year":"2013","journal-title":"Cathete. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0065","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1039\/b820162p","article-title":"Synthesis of polycaprolactone: a review","volume":"38","author":"Labet","year":"2009","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2021.04.050_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.progpolymsci.2019.05.004","article-title":"Degradation mechanisms of polycaprolactone in the context of chemistry, geometry and environment","volume":"96","author":"Bartnikowski","year":"2019","journal-title":"Progr. Polym. Sci."},{"key":"10.1016\/j.actbio.2021.04.050_bib0067","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/09205063.2017.1394711","article-title":"PCL and PCL-based materials in biomedical applications","volume":"29","author":"Malikmammadov","year":"2018","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.actbio.2021.04.050_bib0068","doi-asserted-by":"crossref","DOI":"10.1088\/1748-6041\/3\/2\/025010","article-title":"Electrospun PCL nanofibers with anisotropic mechanical properties as a biomedical scaffold","volume":"3","author":"Kim","year":"2008","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0069","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.msec.2017.08.022","article-title":"Design and fabrication of auxetic PCL nanofiber membranes for biomedical applications","volume":"81","author":"Bhullar","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.actbio.2021.04.050_bib0070","first-page":"55","article-title":"A history of ASD Closure a review of atrial septal closure, including the surgical evolution and the subsequent progression of transcatheter device closure","author":"Terry D. King","year":"2010","journal-title":"Cardiac. Interv. Today"},{"key":"10.1016\/j.actbio.2021.04.050_bib0071","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jmbbm.2014.04.012","article-title":"The mechanical behavior and biocompatibility of polymer blends for Patent Ductus Arteriosus (PDA) occlusion device","volume":"36","author":"Huang","year":"2014","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0072","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ccd.22517","article-title":"A biodegradable device (BioSTAR\u2122) for atrial septal defect closure in children","volume":"76","author":"Morgan","year":"2010","journal-title":"Cathete. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0073","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/17434440.4.6.781","article-title":"BioSTAR bioabsorbable septal repair implant","volume":"4","author":"Mullen","year":"2007","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.actbio.2021.04.050_bib0074","first-page":"184","article-title":"Bioabsorbable atrial septal occluder for percutaneous closure of atrial septal defect in children","volume":"39","author":"Baspinar","year":"2012","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.actbio.2021.04.050_bib0075","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/CIRCULATIONAHA.106.664672","article-title":"BioSTAR Evaluation STudy (BEST):a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts","volume":"114","author":"Mullen","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.actbio.2021.04.050_bib0076","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/btm2.10066","article-title":"Translation in cardiovascular stents and occluders: from biostable to fully degradable","volume":"2","author":"Huang","year":"2017","journal-title":"Bioeng. Trans. Med."},{"key":"10.1016\/j.actbio.2021.04.050_bib0077","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF02629163","article-title":"Monodisk: device for percutaneous transcatheter closure of cardiac septal defects","volume":"16","author":"Pavcnik","year":"1993","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0078","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ccd.22429","article-title":"BioDisk: a new device for closure of patent foramen ovale: a feasibility study in swine","volume":"75","author":"Pavcnik","year":"2010","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0079","first-page":"1160","article-title":"Left Atrial appendage ligation and exclusion technology in the incubator","volume":"2","author":"Syed","year":"2015","journal-title":"J. Atr. Fibrillat."},{"key":"10.1016\/j.actbio.2021.04.050_bib0080","series-title":"Atrial Septal Defect","article-title":"Historical aspects of transcatheter occlusion of atrial septal defects","author":"Alapati","year":"2012"},{"key":"10.1016\/j.actbio.2021.04.050_bib0081","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10856-015-5422-6","article-title":"A fully biodegradable patent ductus arteriosus occlude","volume":"26","author":"Huang","year":"2015","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.actbio.2021.04.050_bib0082","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3724\/SP.J.1008.2013.00660","article-title":"In vitro degradation property and mechanical force test of a bioresorbable ventricular septal defect occluder","volume":"34","author":"Zhu","year":"2013","journal-title":"Acad. J. Second Military Med. Univ."},{"key":"10.1016\/j.actbio.2021.04.050_bib0083","first-page":"257","article-title":"Transcatheter closure of secundum atrial septal defects","volume":"25","author":"Kazmouz","year":"2013","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0084","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0735-1097(02)01711-4","article-title":"Early and late complications associated with transcatheter occlusion of secundum atrial septal defect","volume":"39","author":"Chessa","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0085","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.ijcard.2007.07.072","article-title":"Presentation of an embolised amplatzer septal occluder to the main pulmonary artery 2 years after implantation","volume":"131","author":"Lysitsas","year":"2009","journal-title":"Intern. J. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0086","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/ccd.20211","article-title":"Erosion of amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk","volume":"63","author":"Amin","year":"2004","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0087","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11431-019-1468-2","article-title":"4D printing of personalized shape memory polymer vascular stents with negative Poisson's ratio structure: a preliminary study","volume":"63","author":"Lin","year":"2020","journal-title":"Sci. China Technol. Sci."},{"key":"10.1016\/j.actbio.2021.04.050_bib0088","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nmat4544","article-title":"Biomimetic 4D printing","volume":"15","author":"Gladman","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0089","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s12274-019-2340-9","article-title":"A novel near-infrared light responsive 4D printed nanoarchitecture with dynamically and remotely controllable transformation","volume":"12","author":"Cui","year":"2019","journal-title":"Nano Res."},{"key":"10.1016\/j.actbio.2021.04.050_bib0090","doi-asserted-by":"crossref","first-page":"22768","DOI":"10.1021\/acsami.9b06081","article-title":"3D Printing of auxetic metamaterials with digitally reprogrammable shape","volume":"11","author":"Lei","year":"2019","journal-title":"ACS Appl. Mater.Interfaces"},{"key":"10.1016\/j.actbio.2021.04.050_bib0091","doi-asserted-by":"crossref","DOI":"10.1002\/admt.201800233","article-title":"Stereolithography for personalized left atrial appendage occluders","volume":"3","author":"Robinson","year":"2018","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0092","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202000522","article-title":"Light-coded digital crystallinity patterns toward bioinspired 4D transformation of shape-memory polymers","volume":"30","author":"Peng","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0093","article-title":"Programmed shape-morphing scaffolds enabling facile 3D endothelialization","author":"Zhao","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0094","article-title":"Reconfiguration, camouflage, and color-shifting for bioinspired adaptive hydrogel-based millirobots","volume":"30","author":"Du","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0095","article-title":"Self-unfolding flexible microelectrode arrays based on shape memory polymers","volume":"4","author":"Wang","year":"2019","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0096","doi-asserted-by":"crossref","DOI":"10.1039\/D0LC00569J","article-title":"Shape-adaptable biodevices for wearable and implantable applications","author":"Zhao","year":"2020","journal-title":"Lab Chip"},{"key":"10.1016\/j.actbio.2021.04.050_bib0097","doi-asserted-by":"crossref","first-page":"24748","DOI":"10.1039\/C8TA04763D","article-title":"Tunable shape memory polymer mold for multiple microarray replications","volume":"6","author":"Wang","year":"2018","journal-title":"J. Mater. Chem. A Mater. Energ. Sustain."},{"key":"10.1016\/j.actbio.2021.04.050_bib0098","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jjcc.2019.02.002","article-title":"3D printing and biocompatibility study of a new biodegradable occluder for cardiac defect","volume":"74","author":"Sun","year":"2019","journal-title":"J. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0099","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00246-007-9079-x","article-title":"Cribriform amplatzer device closure of fenestrated atrial septal defects: feasibility and technical aspects","volume":"29","author":"Numan","year":"2008","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ccd.27899","article-title":"A randomized, controlled, multi-center trial of the efficacy and safety of the occlutech figulla flex-ii occluder compared to the amplatzer septal occluder for transcatheter closure of secundum atrial septal defects","volume":"93","author":"Kenny","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0101","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2017.07.058","article-title":"Occlutech percutaneous patent foramen ovale closure: safety and efficacy registry (OPPOSE)","volume":"245","author":"Hildick-Smith","year":"2017","journal-title":"Intern. J. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0102","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.jacc.2006.11.053","article-title":"Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects","volume":"49","author":"Jones","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0103","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ccd.26993","article-title":"Closure of patent foramen ovale defects using GORE\u00ae CARDIOFORM septal occluder: results from a prospective european multicenter study","volume":"90","author":"Hardt","year":"2017","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0104","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/ccd.28728","article-title":"ASSURED clinical study: new GORE\u00ae CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect","volume":"95","author":"Sommer","year":"2020","journal-title":"Catheter. Cardiovasc.Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4244\/EIJY14M07_04","article-title":"A multicentre, comparative study of Cera septal occluder versus AMPLATZER Septal Occluder in transcatheter closure of secundum atrial septal defects","volume":"10","author":"Kaya","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.actbio.2021.04.050_bib0106","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12928-016-0440-y","article-title":"Large single centre experience with the Cera\u2122 and CeraFlex\u2122 occluders for closure of interatrial communications: usefulness of the flexible rotation feature","volume":"33","author":"Apostolopoulou","year":"2018","journal-title":"Cardiovasc. Interv. Ther."},{"issue":"Suppl 2","key":"10.1016\/j.actbio.2021.04.050_bib0107","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00059-014-4192-0","article-title":"Ceraflex versus Amplatzer occluder for secundum atrial septal defect closure. Multicenter clinical experience","volume":"40","author":"Astarcioglu","year":"2015","journal-title":"Herz"},{"key":"10.1016\/j.actbio.2021.04.050_bib0108","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jacc.2006.03.049","article-title":"Device closure rates of simple atrial septal defects optimized by the starflex device","volume":"48","author":"Nugent","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0109","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S1047951118000100","article-title":"Atrial septal defect closure with the new Cardia Ultrasept II device with interposed Goretex patch Mexican experience-has the perforation of Ivalon's membrane been solved","volume":"28","author":"Mijangos-V\u00e1zquez","year":"2018","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.actbio.2021.04.050_bib0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijcard.2014.09.006","article-title":"Catheter closure of atrial septal defects using the cocoon septal occluder: preliminary results of a european multicenter study","volume":"177","author":"Thanopoulos","year":"2014","journal-title":"Intern. J. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.actbio.2021.04.050_bib0111","first-page":"S107","article-title":"New PFO device for closure of patent foramen ovale in patients who had a history of cryptogenic stroke; a report of 14 cases","volume":"98","author":"Srimahachota","year":"2015","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.actbio.2021.04.050_bib0112","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/2150135119845257","article-title":"Developing high medical technology, a challenge for developing countries: the percutaneous closure of atrial septal defects using nit-occlud ASD-R: Early and Mid-term Results","volume":"10","author":"Heath","year":"2019","journal-title":"World J.Pediatr.Congenit. Heart Surg."},{"key":"10.1016\/j.actbio.2021.04.050_bib0113","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00246-016-1426-3","article-title":"Initial experience with the Nit-Occlud ASD-R: short-term results","volume":"37","author":"Bulut","year":"2016","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0114","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ccd.27386","article-title":"Interventional closure of patent foramen ovale with Nit-occlud\u00ae device in prevention of recurrent neurologic events-long-term results","volume":"92","author":"Araszkiewicz","year":"2018","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0115","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/ccd.25580","article-title":"Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud\u00ae in patients with stroke or transient ischemic attack","volume":"85","author":"Steinberg","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0116","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijcard.2009.03.086","article-title":"Interventional closure of atrial septal defects with the solysafe septal occluder- preliminary results in children","volume":"143","author":"Kretschmar","year":"2010","journal-title":"Intern. J. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0117","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ccd.21360","article-title":"ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study","volume":"71","author":"Ewert","year":"2008","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0118","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/ccd.23399","article-title":"Wire fractures in Solysafe septal occluders: a single center experience","volume":"79","author":"Gielen","year":"2012","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0119","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ccd.22713","article-title":"Premere occlusion system for transcatheter patent foramen ovale closure: mid-term results of a single-center registry","volume":"77","author":"Rigatelli","year":"2011","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijcard.2018.03.059","article-title":"Is the new Occlutech duct occluder an appropriate device for transcatheter closure of patent ductus arteriosus?","volume":"261","author":"Godart","year":"2018","journal-title":"Intern. J.Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0121","first-page":"513","article-title":"Percutaneous closure of the patent ductus arteriosus using the Nit-Occlud PDA-R (reverse) device: initial experience reporting immediate and short-term results","volume":"23","author":"Peirone","year":"2011","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0122","first-page":"77","article-title":"Percutaneous closure of a patent ductus arteriosus with the Cera\u2122 PDA Occluder: another good option in the toolbox","volume":"20","author":"Chami\u00e9","year":"2012","journal-title":"Revista Brasileira de Cardiologia Invasiva"},{"key":"10.1016\/j.actbio.2021.04.050_bib0123","first-page":"B272","article-title":"TCT-854 prospective evaluation of feasibility, safety, and efficacy of cocoon duct occluder for transcatheter closure of large patent ductus arteriosus: a single-centre study with short- and medium-term follow-up results","volume":"70","author":"Sinha","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0124","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00246-016-1502-8","article-title":"Interventional VSD-Closure with the Nit-Occlud\u00ae L\u00ea VSD-Coil in 110 patients: early and midterm results of the EUREVECO-registry","volume":"38","author":"Haas","year":"2017","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00246-013-0860-8","article-title":"Transcatheter closure of perimembranous ventricular septal defects using Nit-Occlud\u00ae L\u00ea VSD coil: early and mid-term results","volume":"35","author":"Odemis","year":"2014","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2020.02.056","article-title":"Use of Lifetech\u2122 Konar-MF, a device for both perimembranous and muscular ventricular septal defects: a multicentre study","author":"Tanidir","year":"2020","journal-title":"Intern. J. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0127","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ccd.24371","article-title":"Occlusion of the perimembranous ventricular septal defect using CERA(R) devices","volume":"80","author":"Esteves","year":"2012","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4250\/jcvi.2018.26.e19","article-title":"Early experiences using cocoon occluders for closure of a ventricular septal defect","volume":"3","author":"Park","year":"2018","journal-title":"J. Cardiovasc Imag."},{"key":"10.1016\/j.actbio.2021.04.050_bib0129","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4244\/EIJV6I2A35","article-title":"PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study","volume":"6","author":"Bayard","year":"2010","journal-title":"EuroIntervention."},{"key":"10.1016\/j.actbio.2021.04.050_bib0130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tcm.2015.06.006","article-title":"Editorial commentary: percutaneous left atrial appendage closure for stroke prevention","volume":"26","author":"Saw","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.actbio.2021.04.050_bib0131","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.carrev.2017.04.018","article-title":"First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure","volume":"18","author":"Seeger","year":"2017","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.actbio.2021.04.050_bib0132","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ccd.23136","article-title":"Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience","volume":"79","author":"Lam","year":"2012","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0133","first-page":"47","article-title":"Left atrial appendage closure devices for cardiovascular risk reduction in atrial fibrillation patients","volume":"6","author":"Cruz-Gonzalez","year":"2015","journal-title":"Res. Rep. Clin. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0134","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4244\/EIJV8I9A167","article-title":"The Amplatzer\u2122 Cardiac Plug 2 for left atrial appendage occlusion: Novel features and first-in-man experience","volume":"8","author":"Freixa","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.actbio.2021.04.050_bib0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.carrev.2013.04.003","article-title":"A new left atrial appendage occluder (Lifetech LAmbreTM Device) for stroke prevention in atrial fibrillation","volume":"14","author":"Lam","year":"2013","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.actbio.2021.04.050_bib0136","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.ijcard.2014.09.194","article-title":"Percutaneous left atrial appendage closure with a novel self-modelizing device: a pre-clinical feasibility study","volume":"177","author":"Park","year":"2014","journal-title":"Intern. J. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0137","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1253\/circj.CJ-17-0412","article-title":"Percutaneous left atrial appendage closure With LACBES((R)) Occluder- a preclinical feasibility study","volume":"82","author":"Tang","year":"2017","journal-title":"Circ. J."},{"key":"10.1016\/j.actbio.2021.04.050_bib0138","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jcin.2018.05.023","article-title":"Percutaneous left atrial appendage closure with the ultraseal device: insights from the initial multicenter experience","volume":"11","author":"Asmarats","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.actbio.2021.04.050_bib0139","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrcardio.2013.158","article-title":"Mechanical antithrombotic intervention by LAA occlusion in atrial fibrillation","volume":"10","author":"Yu","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.carrev.2013.04.001","article-title":"Novel percutaneous left atrial appendage closure","volume":"14","author":"Bruce","year":"2013","journal-title":"Cardovasc. Revasc. Med."},{"key":"10.1016\/j.actbio.2021.04.050_bib0141","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0002-9149(02)02280-4","article-title":"Transcatheter patch correction of secundum atrial septal defects","volume":"89","author":"Sideris","year":"2002","journal-title":"Am. J.Cardiol."},{"key":"10.1016\/j.actbio.2021.04.050_bib0142","doi-asserted-by":"crossref","DOI":"10.1002\/adem.201901074","article-title":"Advanced manufacturing of patient-specific occluders for the left atrial appendage with minimally invasive delivery","volume":"22","author":"Alaie","year":"2020","journal-title":"Adv. Eng. Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0143","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jmbbm.2017.07.033","article-title":"An experimental canine patent ductus arteriosus occlusion device based on shape memory polymer foam in a nitinol cage","volume":"75","author":"Wierzbicki","year":"2017","journal-title":"J. Mech Behav.Biomedi. Mater."},{"key":"10.1016\/j.actbio.2021.04.050_bib0144","article-title":"4D Printing of bioinspired absorbable left atrial appendage occluders: a proof-of-concept study","author":"Lin","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2021.04.050_bib0146","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.polymdegradstab.2014.11.013","article-title":"In vitro degradation behavior of l-lactide\/trimethylene carbonate\/glycolide terpolymers and a composite with poly(l-lactide-co-glycolide) fibers","volume":"111","author":"Liao","year":"2015","journal-title":"Polym. Degrad. Stabil."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121002968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121002968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:52:28Z","timestamp":1724457148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706121002968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":146,"alternative-id":["S1742706121002968"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2021.04.050","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent developments in next-generation occlusion devices","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2021.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}